Showing 5681-5690 of 5956 results for "".
- Healthe Named One of the Nation’s 20 Hottest Health Start-Upshttps://modernod.com/news/healthe-named-one-of-the-nations-20-hottest-health-start-ups/2476213/Healthe, an eye health company that develops products and technology to block ultra-violet and high-energy visible blue light, announced that it was selected by THE OBSERVER as one of the nation’s hottest digital health companies. The list focuses on non-coastal, start-ups from the Midwest, South
- Staar Surgical Expects Fourth Quarter ICL Sales to Rise 42%; China Units Nearly Double, U.S. Market Returns to Growthhttps://modernod.com/news/staar-surgical-expects-fourth-quarter-icl-sales-to-rise-42-china-units-nearly-double-u-s-market-returns-to-growth/2476216/Staar Surgical, which provided preliminary sales results for the fourth quarter ending December 28, 2018, said it expects fourth quarter ICL net sales to increase approximately 42% over the prior year period. Total net sales for the fourth quarter are expected to be approximately $31.2 million an
- Aerie Pharmaceuticals Announces Positive Topline Results of Netarsudil Ophthalmic Solution in Pilot Phase 2 Studyhttps://modernod.com/news/aerie-pharmaceuticals-announces-positive-topline-results-of-netarsudil-ophthalmic-solution-in-pilot-phase-2-study/2476219/Aerie Pharmaceuticals announced the topline results of its pilot phase 2 study of netarsudil ophthalmic solution in a Japanese-American population. The study was designed in accordance with the requirements of Japan’s PMDA (Pharmaceuticals and Medical Devices Agency) to support the potential regu
- Focus Vision Supplements Launches Reformulated Version of Omega-3 Focus Relief Plushttps://modernod.com/news/focus-vision-supplements-launches-reformulated-version-of-omega-3-focus-relief-plus/2476228/Covalent Medical, a network of over 385 ophthalmologists who distribute vision supplements sold in practitioners’ offices in the United States under the brand name Focus Vision Supplements, is launching a reformulated version of their leading omega-3 formulation Focus Relief Plus. Focus Re
- Results RNA Issues Voluntary Worldwide Recall of Lubrisine Eye Drops Due to Manufacturing Sterility Concerns and Undeclared Colloidal Silverhttps://modernod.com/news/results-rna-issues-voluntary-worldwide-recall-of-lubrisine-eye-drops-due-to-manufacturing-sterility-concerns-and-undeclared-colloidal-silver/2476230/Results RNA is voluntarily recalling Lubrisine Eye Drops to the healthcare practitioner, retail or consumer level. This product, in a recent FDA inspection, was found to be manufactured using practices that do not support its sterility and contained undeclared colloidal silver.
- American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Carehttps://modernod.com/news/american-academy-of-ophthalmology-calls-on-states-to-maintain-high-safety-standards-for-surgical-eye-care/2476237/The American Academy of Ophthalmology agrees with important patient safety guidelines recommended in a joint report issued by the three federal agencies that help guide the nation’s health care system. The report, authored by the three cabinet secretaries of the U.S. Departments of Health and Hum
- iSTAR Medical’s MINIject Maintains Exceptional Results in First-in-Human Trial One Year Post-Surgery (STAR-I)https://modernod.com/news/istar-medicals-miniject-maintains-exceptional-results-in-first-in-human-trial-one-year-post-surgery-star-i/2476244/iSTAR Medical announced 1-year results of the first-in-human, microinvasive glaucoma surgery (MIGS) STAR-I trial, for the MINIject device in a standalone setting. Results demonstrate that MINIject is safe and highly effective in achieving significant IOP reduction, as well as easing medication bu
- Beaver-Visitec International to Acquire PhysIOL Grouphttps://modernod.com/news/tpg-capital-backs-bvi-to-acquire-physiol-group-sa/2476246/Beaver-Visitec International (BVI) announced it has signed a definitive agreement to acquire PhysIOL Group, a Belgium-based ophthalmic company specializing in the research, development, and manufacture of IOLs, from TA Associates. Financial terms of the transaction were not disclosed.
- Alcon Acquires Tear Film Innovationshttps://modernod.com/news/alcon-announces-acquisition-of-tear-film-innovations/2476248/Alcon announced that it has acquired Tear Film Innovations, maker of the iLux device to treat meibomian gland dysfunction. Financial terms of the deal were not disclosed. Handheld and portable, the iLux enables eye care professionals to directly target a patient’s blocked meibomian
- Notal Vision Engages Wasatch Photonics Bringing AI-Enabled Home-Based OCT Closer to Markethttps://modernod.com/news/notal-vision-engages-wasatch-photonics-bringing-ai-enabled-home-based-oct-closer-to-market/2479605/Notal Vision has announced the achievement of a significant milestone in its plan to develop and commercialize a home-based, patient-operated, spectral-domain optical coherence tomography (SD-OCT) system. The first targeted application of the Notal Home OCT is to monitor wet age-related macular d